HopeStage
Back to all studies
CompletedNCT04500301

Genetic Testing to Guide Pain and Depression Care in Cancer

About this titleRead the official source — NCT04500301
Interventional studyAges 18+United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
CharlotteSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: December 2, 2020
Recruitment status
Completed
Enrollment listed in the registry
70
Sponsor
Wake Forest University Health Sciences
Sponsor type
University
Study type
Other
Intervention type
Other
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT04500301
Official title
Show the full official title

Evaluating the Use of Preemptive Pharmacogenomic Testing to Personalize Supportive Oncology

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Charlotte

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Wake Forest University Health Sciences, a university.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies